Discover and read the best of Twitter Threads about #JBChemicals
Most recents (2)
#JBChemicals & Pharmaceuticals Q3 FY22 concall highlights 💊💊
Like & Retweet for better reach !
1. They were the fastest growing company among the Top 30 companies in the domestic formulations market as per IQVIA. JB grew at 27% vs market growth of 18%.
Like & Retweet for better reach !
1. They were the fastest growing company among the Top 30 companies in the domestic formulations market as per IQVIA. JB grew at 27% vs market growth of 18%.
2. Revenues for the quarter stood at ₹601 Cr (10% growth YoY).
3. EBITDA excluding ESOP cost stood at ₹153 Cr (10.5% decline YoY). Gross margins for the quarter stood at 66% although there was significant cost inflation.
3. EBITDA excluding ESOP cost stood at ₹153 Cr (10.5% decline YoY). Gross margins for the quarter stood at 66% although there was significant cost inflation.
4. Cost pressure persists on raw material and packing material, which is expected to continue in the medium-term.
5. During Q3 FY22, Domestic Formulations business launched 12 new products including Molnupiravir, Cilacar TM, Azovas-T and Pirfenidone.
5. During Q3 FY22, Domestic Formulations business launched 12 new products including Molnupiravir, Cilacar TM, Azovas-T and Pirfenidone.
#JBChemicals and Pharma: Acquisition from Sanzyme 💊
Like & Retweet for better reach !
1. They have acquired Sanzyme Private Limited’s key brands and related assets related to probiotics, therapeutic nutraceuticals and reproductive health for ~₹628 Cr.
Like & Retweet for better reach !
1. They have acquired Sanzyme Private Limited’s key brands and related assets related to probiotics, therapeutic nutraceuticals and reproductive health for ~₹628 Cr.
This excludes related taxes and stamp duty. They expect to invest around ₹15 Cr separately as working capital for the acquired business.
2. The acquisition is funded through a mix of internal accruals and short term debt. The transaction is expected to complete in the next 2 weeks subject to customary closing formalities.
